Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial
Janssen Research & Development, LLC
Kristian Reich; April W Armstrong; Richard G Langley; Susan Flavin; Bruce Randazzo; Shu Li; Ming-Chun Hsu; Patrick Branigan; Andrew Blauvelt